A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence
F1000Research · 2025
DOI: 10.12688/f1000research.160217.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift F1000Research, 2025. Verfasst von Vera Ruíz Moleón und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Québec, Canada. Hauptthemen laut MEDLINE: Stearoyl-CoA Desaturase, Immunoprecipitation, Blotting, Western, Fluorescent Antibody Technique. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Michael J. Fox Foundation for Parkinson's Research, Mitacs, Ontario Genomics.
Abstract (Originalsprache)
The enzyme stearoyl-CoA desaturase (SCD1) is a modulator of lipid metabolism by catalyzing the biosynthesis of mono-unsaturated fatty acids from saturated fatty acids. Understanding the specific mechanisms by which SCD1 plays in health and disease can provide novel insides in therapeutic targets, a process that would be facilitated by the availability of high-quality antibodies. Here we have characterized nine SCD1 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, Montreal, Québec, Canada.
ORCID-Profile: Vera Ruíz Moleón, Charles Alende, Sara González Bolívar, Carl Laflamme
Förderung
- Michael J. Fox Foundation for Parkinson's Research
- Mitacs
- Ontario Genomics
- Génome Québec
- Genome Canada
Zitieren
APA
Ruíz Moleón, V., Alende, C., Fotouhi, M., González Bolívar, S., Ayoubi, R., Laflamme, C., NeuroSGC/YCharOS/EDDU collaborative group, & ABIF consortium (2025). A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.160217.2
Vancouver
Ruíz Moleón V, Alende C, Fotouhi M, González Bolívar S, Ayoubi R, Laflamme C, et al. A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence. F1000Research. 2025. doi:10.12688/f1000research.160217.2
BibTeX
@article{RuzMolen2025,
author = {Ruíz Moleón, Vera and Alende, Charles and Fotouhi, Maryam and González Bolívar, Sara and Ayoubi, Riham and Laflamme, Carl and NeuroSGC/YCharOS/EDDU collaborative group, NeuroSGC/YCharOS/EDDU collaborative group and ABIF consortium, ABIF consortium},
title = {A guide to selecting high-performing antibodies for Stearoyl-CoA desaturase (SCD1) (UniProt ID: O00767) for use in western blot, immunoprecipitation, and immunofluorescence},
journal = {F1000Research},
year = {2025},
doi = {10.12688/f1000research.160217.2}
}
EUVIMED